Gyre Therapeutics is trading at $4.54, down 28.71%, with no publicly disclosed cause identified as of 3:33 p.m. EST on October 30, 2026. - A market-move report likewise said no cause had been publicly disclosed. - U.S. stocks were broadly lower Friday, but available reporting does not establish that market weakness caused the decline. - The latest release shown on Gyre Therapeutics’ investor-relations page is dated September 3; no fresh release surfaced there.